Health & Fitness
Health and Fitness
Health and Fitness
Fri, August 20, 2010
Thu, August 19, 2010
Positron Announces Strategic Alliance with Covidien; to Develop Innovative Distribution Model
INDIANAPOLIS--([ BUSINESS WIRE ])--Positron Corporation (OTCBB:POSC), announced it has signed an agreement with Covidien (NYSE:COV), a leading global provider of healthcare products, under which Covidien will provide technical assistance to Positron in connection with Positrona�s development of technology to automate the compounding of radiopharmaceuticals.
"This agreement provides Positron with various advantages and additional resources. We are very excited to collaborate with Covidien on this project."
The agreement combines Covidiena�s expertise in radiopharmaceuticals and regulatory issues with Positrona�s expertise in automation and radiopharmaceuticals. Automating the distribution of radiopharmaceuticals has many benefits, ranging from worker safety to cost savings to enhanced customer service.
aPositron continues to provide unique solutions to the molecular imaging community,a said John Zehner, COO of Positron. aThis agreement provides Positron with various advantages and additional resources. We are very excited to collaborate with Covidien on this project.a
About Positron: Positron is a molecular imaging company focused on Nuclear Cardiology. Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging to radiopharmaceutical distribution. Positron products include: the Attriusa", a PET imaging device; the Pulse�, a SPECT imaging device; the Nuclear Pharm-Assist�, an automated radiopharmaceutical distribution device; and the Tech-Assista", a radiopharmaceutical injection shield. More information about Positron is available at [ www.positron.com ].
Forward Looking Statements: Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance and may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Positron assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission.
